Main Logo
+17162654855
[email protected]

Europe Autoimmune Disease Diagnostics Market Projected to Grow at XX CAGR: Insights and Forecasts 2026-2034

Europe Autoimmune Disease Diagnostics Market by Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease), by Diagnostic Technique (Immunofluorescence Assays (IFA), Enzyme-linked Immunosorbant Assay (ELISA), Western Blotting, Multiplex Immunoassay, Agglutination, Other Diagnostic Techniques), by Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) Forecast 2026-2034

Base Year: 2025
234 Pages
Main Logo

Europe Autoimmune Disease Diagnostics Market Projected to Grow at XX CAGR: Insights and Forecasts 2026-2034

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of Europe Autoimmune Disease Diagnostics Market

Higher Coverage
Lower Coverage
No Coverage

Europe Autoimmune Disease Diagnostics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 5.69% from 2020-2034
Segmentation
    • By Disease Type
      • Systemic Autoimmune Disease
        • Rheumatoid Arthritis
        • Psoriasis
        • Systemic Lupus Erythematosus (SLE)
        • Multiple Sclerosis
        • Other Systemic Autoimmune Diseases
      • Localized Autoimmune Disease
        • Inflammatory Bowel Disease
        • Type-1 Diabetes
        • Thyroid
        • Other Localized Autoimmune Diseases
    • By Diagnostic Technique
      • Immunofluorescence Assays (IFA)
      • Enzyme-linked Immunosorbant Assay (ELISA)
      • Western Blotting
      • Multiplex Immunoassay
      • Agglutination
      • Other Diagnostic Techniques
  • By Geography
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Disease Type
      • 5.1.1. Systemic Autoimmune Disease
        • 5.1.1.1. Rheumatoid Arthritis
        • 5.1.1.2. Psoriasis
        • 5.1.1.3. Systemic Lupus Erythematosus (SLE)
        • 5.1.1.4. Multiple Sclerosis
        • 5.1.1.5. Other Systemic Autoimmune Diseases
      • 5.1.2. Localized Autoimmune Disease
        • 5.1.2.1. Inflammatory Bowel Disease
        • 5.1.2.2. Type-1 Diabetes
        • 5.1.2.3. Thyroid
        • 5.1.2.4. Other Localized Autoimmune Diseases
    • 5.2. Market Analysis, Insights and Forecast - by Diagnostic Technique
      • 5.2.1. Immunofluorescence Assays (IFA)
      • 5.2.2. Enzyme-linked Immunosorbant Assay (ELISA)
      • 5.2.3. Western Blotting
      • 5.2.4. Multiplex Immunoassay
      • 5.2.5. Agglutination
      • 5.2.6. Other Diagnostic Techniques
    • 5.3. Market Analysis, Insights and Forecast - by Region
      • 5.3.1. Europe
  6. 6. Europe Autoimmune Disease Diagnostics Market Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Disease Type
      • 6.1.1. Systemic Autoimmune Disease
        • 6.1.1.1. Rheumatoid Arthritis
        • 6.1.1.2. Psoriasis
        • 6.1.1.3. Systemic Lupus Erythematosus (SLE)
        • 6.1.1.4. Multiple Sclerosis
        • 6.1.1.5. Other Systemic Autoimmune Diseases
      • 6.1.2. Localized Autoimmune Disease
        • 6.1.2.1. Inflammatory Bowel Disease
        • 6.1.2.2. Type-1 Diabetes
        • 6.1.2.3. Thyroid
        • 6.1.2.4. Other Localized Autoimmune Diseases
    • 6.2. Market Analysis, Insights and Forecast - by Diagnostic Technique
      • 6.2.1. Immunofluorescence Assays (IFA)
      • 6.2.2. Enzyme-linked Immunosorbant Assay (ELISA)
      • 6.2.3. Western Blotting
      • 6.2.4. Multiplex Immunoassay
      • 6.2.5. Agglutination
      • 6.2.6. Other Diagnostic Techniques
  7. 7. Competitive Analysis
      • 7.1. Company Profiles
        • 7.1.1 Inova Diagnostics Inc
          • 7.1.1.1. Company Overview
          • 7.1.1.2. Products
          • 7.1.1.3. Company Financials
          • 7.1.1.4. SWOT Analysis
        • 7.1.2 Thermo Fisher Scientific Inc
          • 7.1.2.1. Company Overview
          • 7.1.2.2. Products
          • 7.1.2.3. Company Financials
          • 7.1.2.4. SWOT Analysis
        • 7.1.3 Abbott Laboratories
          • 7.1.3.1. Company Overview
          • 7.1.3.2. Products
          • 7.1.3.3. Company Financials
          • 7.1.3.4. SWOT Analysis
        • 7.1.4 Biomerieux Inc
          • 7.1.4.1. Company Overview
          • 7.1.4.2. Products
          • 7.1.4.3. Company Financials
          • 7.1.4.4. SWOT Analysis
        • 7.1.5 Euroimmun AG
          • 7.1.5.1. Company Overview
          • 7.1.5.2. Products
          • 7.1.5.3. Company Financials
          • 7.1.5.4. SWOT Analysis
        • 7.1.6 Siemens Healthineers Inc
          • 7.1.6.1. Company Overview
          • 7.1.6.2. Products
          • 7.1.6.3. Company Financials
          • 7.1.6.4. SWOT Analysis
        • 7.1.7 Bio-rad Laboratories
          • 7.1.7.1. Company Overview
          • 7.1.7.2. Products
          • 7.1.7.3. Company Financials
          • 7.1.7.4. SWOT Analysis
        • 7.1.8 Myriad Genetics
          • 7.1.8.1. Company Overview
          • 7.1.8.2. Products
          • 7.1.8.3. Company Financials
          • 7.1.8.4. SWOT Analysis
        • 7.1.9 F Hoffmann-la Roche
          • 7.1.9.1. Company Overview
          • 7.1.9.2. Products
          • 7.1.9.3. Company Financials
          • 7.1.9.4. SWOT Analysis
        • 7.1.10 Trinity Biotech PLC
          • 7.1.10.1. Company Overview
          • 7.1.10.2. Products
          • 7.1.10.3. Company Financials
          • 7.1.10.4. SWOT Analysis
      • 7.2. Market Entropy
        • 7.2.1 Company's Key Areas Served
        • 7.2.2 Recent Developments
      • 7.3. Company Market Share Analysis 2025
        • 7.3.1 Top 5 Companies Market Share Analysis
        • 7.3.2 Top 3 Companies Market Share Analysis
    • 7.4. List of Potential Customers
  8. 8. Research Methodology

    List of Figures

    1. Figure 1: Europe Autoimmune Disease Diagnostics Market Revenue Breakdown (Million, %) by Product 2025 & 2033
    2. Figure 2: Europe Autoimmune Disease Diagnostics Market Share (%) by Company 2025

    List of Tables

    1. Table 1: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Disease Type 2020 & 2033
    2. Table 2: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Diagnostic Technique 2020 & 2033
    3. Table 3: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Region 2020 & 2033
    4. Table 4: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Disease Type 2020 & 2033
    5. Table 5: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Diagnostic Technique 2020 & 2033
    6. Table 6: Europe Autoimmune Disease Diagnostics Market Revenue Million Forecast, by Country 2020 & 2033
    7. Table 7: Germany Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033
    8. Table 8: United Kingdom Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033
    9. Table 9: France Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033
    10. Table 10: Italy Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033
    11. Table 11: Spain Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033
    12. Table 12: Rest of Europe Europe Autoimmune Disease Diagnostics Market Revenue (Million) Forecast, by Application 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Autoimmune Disease Diagnostics Market?

    The projected CAGR is approximately 5.69%.

    2. Which companies are prominent players in the Europe Autoimmune Disease Diagnostics Market?

    Key companies in the market include Inova Diagnostics Inc, Thermo Fisher Scientific Inc, Abbott Laboratories, Biomerieux Inc, Euroimmun AG, Siemens Healthineers Inc, Bio-rad Laboratories, Myriad Genetics, F Hoffmann-la Roche, Trinity Biotech PLC.

    3. What are the main segments of the Europe Autoimmune Disease Diagnostics Market?

    The market segments include Disease Type, Diagnostic Technique.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 1.38 Million as of 2022.

    5. What are some drivers contributing to market growth?

    ; Increasing Prevalence and Rising Public Awareness; Technological Advancements and Improved Laboratory Automation.

    6. What are the notable trends driving market growth?

    Rheumatoid Arthritis is Expected to Dominate the Systemic Autoimmune Disease Segment in the Coming Future.

    7. Are there any restraints impacting market growth?

    ; Slow Turnaround Time of Results and Need of Multiple Diagnostic Test; High Cost.

    8. Can you provide examples of recent developments in the market?

    N/A

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in Million.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "Europe Autoimmune Disease Diagnostics Market," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the Europe Autoimmune Disease Diagnostics Market report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the Europe Autoimmune Disease Diagnostics Market?

    To stay informed about further developments, trends, and reports in the Europe Autoimmune Disease Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.